Literature DB >> 25480734

Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma.

Xiaodong Zhou1, Ruiguo Zheng, Huifang Zhang, Tianlin He.   

Abstract

Liver cancer is the third most common cause of cancer death in the world. Hepatocellular carcinoma (HCC) is the main pathological types in liver cancer, which amounts to 70-85 % of primary liver cancer in the world and 90 % in China. The aim of this study was to establish a PPI network and a pathway crosstalk network to isolate important dysfunctional pathways which play an important role in the pathogenesis of HCC. System biology approach was used in this research. A PPI network was firstly built and then a dysfunctional crosstalk network of HCC related pathways was constructed. Several important significant dysfunctional crosstalk pathways were identified. Basal transcription factors (hsa03022), Glycerophospholipid metabolism (hsa00564) and Metabolism of xenobiotics by cytochrome P450 (hsa00980) were significantly interact with Pathway in cancer (hsa05200). Besides, pathway Axon guidance (hsa04360) was also dysfunctional crosstalk with Pathway in cancer (hsa05200). The crosstalks among these pathways reveal some evidence that the pathways closely cooperated and play important tasks in HCC progression. Besides, the pathway hsa04360 dysfunctional crosstalk with the hsa05200 indicates there would be a same mechanism for HCC invasion and migration.

Entities:  

Mesh:

Year:  2014        PMID: 25480734     DOI: 10.1007/s12253-014-9855-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  39 in total

Review 1.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 2.  Protein networks in disease.

Authors:  Trey Ideker; Roded Sharan
Journal:  Genome Res       Date:  2008-04       Impact factor: 9.043

3.  Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.

Authors:  Guoqing Pan; Xiangling Zhang; Junyu Ren; Jianbo Lu; Wenliang Li; Hongmei Fu; Shufang Zhang; Jun Li
Journal:  Pathol Oncol Res       Date:  2012-07-21       Impact factor: 3.201

Review 4.  Molecular pathology of non-small-cell lung cancer.

Authors:  R H J Breuer; P E Postmus; E F Smit
Journal:  Respiration       Date:  2005 May-Jun       Impact factor: 3.580

Review 5.  Cyclin D-dependent kinases, INK4 inhibitors and cancer.

Authors:  Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Biochim Biophys Acta       Date:  2002-03-14

6.  Inferring pathway crosstalk networks using gene set co-expression signatures.

Authors:  Ting Wang; Jin Gu; Jun Yuan; Ran Tao; Yanda Li; Shao Li
Journal:  Mol Biosyst       Date:  2013-04-17

7.  Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.

Authors:  B Roy; R Taneja; P Chambon
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

Review 8.  Cytochrome P450 pharmacogenetics and cancer.

Authors:  C Rodriguez-Antona; M Ingelman-Sundberg
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

9.  Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis.

Authors:  Kristen E N Scott; Frances B Wheeler; Amanda L Davis; Michael J Thomas; James M Ntambi; Darren F Seals; Steven J Kridel
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

10.  Semaphorin 5A promotes gastric cancer invasion/metastasis via urokinase-type plasminogen activator/phosphoinositide 3-kinase/protein kinase B.

Authors:  Guoqing Pan; Zhu Zhu; Jian Huang; Chenggang Yang; Ying Yang; Yingxia Wang; Xiaoyu Tuo; Guomiao Su; Xiangling Zhang; Zhi Yang; Tao Liu
Journal:  Dig Dis Sci       Date:  2013-05-10       Impact factor: 3.199

View more
  3 in total

1.  A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.

Authors:  Feifei Wang; Ruliang Wang; Qiuwen Li; Xueling Qu; Yixin Hao; Jingwen Yang; Huixia Zhao; Qian Wang; Guanghui Li; Fengyun Zhang; He Zhang; Xuan Zhou; Xioumei Peng; Yang Bian; Wenhua Xiao
Journal:  Diagn Pathol       Date:  2017-01-13       Impact factor: 2.644

2.  Comparison of Transcriptomics Changes Induced by TCS and MTCS Exposure in Human Hepatoma HepG2 Cells.

Authors:  Xiaoqian Li; Yu Shang; Weiwei Yao; Yi Li; Ning Tang; Jing An; Yongjie Wei
Journal:  ACS Omega       Date:  2020-05-06

3.  A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.

Authors:  Xiaofeng Yin; Jinchuan Li; Zheng Hao; Rui Ding; Yanan Qiao
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.